Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Mol Genet ; 27(16): 2789-2804, 2018 08 15.
Article in English | MEDLINE | ID: mdl-29771332

ABSTRACT

Myotonic dystrophy type 1 (DM1) is a multi-systemic disease resulting in severe muscle weakening and wasting. DM1 is caused by expansion of CTG repeats in the 3' untranslated region of the dystrophia myotonica protein kinase (DMPK) gene. We have developed an inducible, skeletal muscle-specific mouse model of DM1 (CUG960) that expresses 960 CUG repeat-expressing animals (CUG960) in the context of human DMPK exons 11-15. CUG960 RNA-expressing mice induced at postnatal day 1, as well as adult-onset animals, show clear, measurable muscle wasting accompanied by severe histological defects including central myonuclei, reduced fiber cross-sectional area, increased percentage of oxidative myofibers, the presence of nuclear RNA foci that colocalize with Mbnl1 protein, and increased Celf1 protein in severely affected muscles. Importantly, muscle loss, histological abnormalities and RNA foci are reversible, demonstrating recovery upon removal of toxic RNA. RNA-seq and protein array analysis indicate that the balance between anabolic and catabolic pathways that normally regulate muscle mass may be disrupted by deregulation of platelet derived growth factor receptor ß signaling and the PI3K/AKT pathways, along with prolonged activation of AMP-activated protein kinase α signaling. Similar changes were detected in DM1 skeletal muscle compared with unaffected controls. The mouse model presented in this paper shows progressive skeletal muscle wasting and has been used to identify potential molecular mechanisms underlying skeletal muscle loss. The reversibility of the phenotype establishes a baseline response for testing therapeutic approaches.


Subject(s)
Muscle Weakness/genetics , Myotonic Dystrophy/genetics , Myotonin-Protein Kinase/genetics , Animals , Base Sequence , CELF1 Protein , DNA-Binding Proteins , Disease Models, Animal , Humans , Mice , Muscle Weakness/pathology , Muscle, Skeletal/physiopathology , Myotonic Dystrophy/pathology , RNA-Binding Proteins , Trinucleotide Repeat Expansion
2.
Hum Genet ; 136(9): 1247-1263, 2017 09.
Article in English | MEDLINE | ID: mdl-28484853

ABSTRACT

An emerging class of long noncoding RNAs (lncRNAs) function as decoy molecules that bind and sequester proteins thereby inhibiting their normal functions. Titration of proteins by lncRNAs has wide-ranging effects affecting nearly all steps in gene expression. While decoy lncRNAs play a role in normal physiology, RNAs expressed from alleles containing nucleotide repeat expansions can be pathogenic due to protein sequestration resulting in disruption of normal functions. This review focuses on commonalities between decoy lncRNAs that regulate gene expression by competitive inhibition of protein function through sequestration and specific examples of nucleotide repeat expansion disorders mediated by toxic RNA that sequesters RNA-binding proteins and impedes their normal functions. Understanding how noncoding RNAs compete with various RNA and DNA molecules for binding of regulatory proteins will provide insight into how similar mechanisms contribute to disease pathogenesis.


Subject(s)
DNA Repeat Expansion , Genetic Diseases, Inborn , RNA, Long Noncoding , RNA-Binding Proteins , Genetic Diseases, Inborn/genetics , Genetic Diseases, Inborn/metabolism , Humans , RNA, Long Noncoding/genetics , RNA, Long Noncoding/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism
3.
Genetics ; 195(3): 927-40, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24026097

ABSTRACT

wings apart (wap) is a recessive, semilethal gene located on the X chromosome in Drosophila melanogaster, which is required for normal wing-vein patterning. We show that the wap mutation also results in loss of the adult jump muscle. We use complementation mapping and gene-specific RNA interference to localize the wap locus to the proximal X chromosome. We identify the annotated gene CG14614 as the gene affected by the wap mutation, since one wap allele contains a non-sense mutation in CG14614, and a genomic fragment containing only CG14614 rescues the jump-muscle phenotypes of two wap mutant alleles. The wap gene lies centromere-proximal to touch-insensitive larva B and centromere-distal to CG14619, which is tentatively assigned as the gene affected in introverted mutants. In mutant wap animals, founder cell precursors for the jump muscle are specified early in development, but are later lost. Through tissue-specific knockdowns, we demonstrate that wap function is required in both the musculature and the nervous system for normal jump-muscle formation. wap/CG14614 is homologous to vertebrate wdr68, DDB1 and CUL4 associated factor 7, which also are expressed in neuromuscular tissues. Thus, our findings provide insight into mechanisms of neuromuscular development in higher animals and facilitate the understanding of neuromuscular diseases that may result from mis-expression of muscle-specific or neuron-specific genes.


Subject(s)
Drosophila melanogaster/growth & development , Drosophila melanogaster/genetics , Genes, Insect , Neuromuscular Junction/growth & development , Neuromuscular Junction/genetics , Animals , Chromosome Mapping , Conserved Sequence , Drosophila melanogaster/physiology , Evolution, Molecular , Female , Gene Expression Regulation, Developmental , Genetic Complementation Test , Male , Mutation , Neuromuscular Junction/physiology , Phenotype , RNA Interference , Wings, Animal/growth & development
4.
Methods Mol Biol ; 798: 127-52, 2012.
Article in English | MEDLINE | ID: mdl-22130835

ABSTRACT

The Drosophila system has been invaluable in providing important insights into mesoderm specification, muscle specification, myoblast fusion, muscle differentiation, and myofibril assembly. Here, we present a series of Drosophila protocols that enable the researcher to visualize muscle precursors and differentiated muscles, at all stages of development. In doing so, we also highlight the variety of techniques that are used to create these findings. These protocols are directly used for the Drosophila system, and are provided with explanatory detail to enable the researcher to apply them to other systems.


Subject(s)
Drosophila melanogaster/embryology , Drosophila melanogaster/growth & development , Muscle Development , Muscle, Skeletal/embryology , Muscle, Skeletal/growth & development , Animals , Body Patterning/physiology , Embryo, Nonmammalian/metabolism , Genes, Reporter/genetics , Immunohistochemistry/methods , In Situ Hybridization/methods , Larva/metabolism , Microscopy, Fluorescence , Staining and Labeling
SELECTION OF CITATIONS
SEARCH DETAIL
...